Press Releases Items Per Page 102550 News Category FinancialGeneral Year None20252024202320222021202020192018201720162015201420132012201120102009200820072006 Nektar Initiates Phase 1 Clinical Study Evaluating NKTR-181, A Novel Opioid Molecule, for Treatment of Pain Mar 21, 2011 AstraZeneca Initiates Phase III Clinical Programme Evaluating NKTR-118 for Treatment of Opioid-Induced Constipation Mar 15, 2011 Nektar Therapeutics Reports Fourth Quarter and Year End 2010 Financial Results Mar 01, 2011 Nektar Therapeutics' President and CEO Howard W. Robin to Present at the 31st Annual Cowen and Company Healthcare Conference in Boston Mar 01, 2011 Nektar to Announce Financial Results for the Fourth Quarter and Year-End of 2010 on Tuesday, March 1, 2011, After Close of U.S.-Based Financial Markets Feb 17, 2011 Nektar Therapeutics Completes Public Offering of Common Stock Jan 24, 2011 Nektar Therapeutics Prices Public Offering of Common Stock Jan 19, 2011 Nektar Therapeutics Announces Proposed Public Offering of Common Stock Jan 18, 2011 Nektar Therapeutics' President and CEO, Howard W. Robin, to Present at the 29th Annual J.P. Morgan Healthcare Conference in San Francisco, CA Jan 05, 2011 NKTR-102 Demonstrates Significant Efficacy as Single-Agent in Second- or Third-Line Treatment in Metastatic Breast Cancer Patients Dec 12, 2010 Pagination First page « first Previous page ‹ previous … Page 35 Page 36 Page 37 Page 38 Current page 39 Page 40 Page 41 Page 42 Page 43 … Next page next › Last page last »